Management of Comedication in Hospitalized COVID-19 Patients With Atrial Fibrillation.
作者信息
Kow Chia Siang, Sunter Wendy, Hasan Syed Shahzad
机构信息
International Medical University, Kuala Lumpur, Malaysia.
Calderdale and Huddersfield NHS Foundation Trust, Huddersfield, UK.
出版信息
Hosp Pharm. 2021 Dec;56(6):629-632. doi: 10.1177/0018578720947354. Epub 2020 Aug 10.
Abstract
摘要
相似文献
1
Management of Comedication in Hospitalized COVID-19 Patients With Atrial Fibrillation.住院COVID-19合并心房颤动患者的联合用药管理
Hosp Pharm. 2021 Dec;56(6):629-632. doi: 10.1177/0018578720947354. Epub 2020 Aug 10.
2
Atrial Fibrillation in Patients Hospitalized With COVID-19: Incidence, Predictors, Outcomes, and Comparison to Influenza.新冠肺炎住院患者的心房颤动：发病率、预测因素、结局及与流感的比较
JACC Clin Electrophysiol. 2021 Sep;7(9):1120-1130. doi: 10.1016/j.jacep.2021.02.009. Epub 2021 Feb 24.
3
The ATRIA score is superior to the m-CHA2DS2-Vasc score in predicting in-hospital mortality in COVID-19.ATRIA 评分优于 m-CHA2DS2-Vasc 评分，可预测 COVID-19 患者住院期间的死亡率。
Rev Assoc Med Bras (1992). 2021 Mar;67(3):443-448. doi: 10.1590/1806-9282.20200983.
4
New-Onset Atrial Fibrillation in Patients Hospitalized With COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Registry.COVID-19 住院患者新发心房颤动：美国心脏协会 COVID-19 心血管登记研究结果。
Circ Arrhythm Electrophysiol. 2022 May;15(5):e010666. doi: 10.1161/CIRCEP.121.010666. Epub 2022 Apr 27.
5
Prevalence of Atrial Fibrillation and Associated Mortality Among Hospitalized Patients With COVID-19: A Systematic Review and Meta-Analysis.新冠病毒肺炎住院患者中心房颤动的患病率及相关死亡率：一项系统评价与荟萃分析
Front Cardiovasc Med. 2021 Oct 13;8:720129. doi: 10.3389/fcvm.2021.720129. eCollection 2021.
6
A COVID-19 Patient Presenting With Paroxysmal Atrial Fibrillation.一名表现为阵发性心房颤动的新冠肺炎患者。
Cureus. 2021 Aug 30;13(8):e17569. doi: 10.7759/cureus.17569. eCollection 2021 Aug.
7
Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study.心房颤动对住院 COVID-19 患者临床病程和结局的影响：Cardio-COVID-Italy 多中心研究结果。
Europace. 2021 Oct 9;23(10):1603-1611. doi: 10.1093/europace/euab146.
8
Outcomes and mortality associated with atrial arrhythmias among patients hospitalized with COVID-19: A systematic review and meta-analysis.COVID-19 住院患者合并房性心律失常的结局和死亡率：系统评价和荟萃分析。
Cardiol J. 2022;29(1):33-43. doi: 10.5603/CJ.a2021.0167. Epub 2021 Dec 13.
9
Outcomes and mortality associated with atrial arrhythmias among patients hospitalized with COVID-19.与 COVID-19 住院患者的心房心律失常相关的结局和死亡率。
J Cardiovasc Electrophysiol. 2020 Dec;31(12):3077-3085. doi: 10.1111/jce.14770. Epub 2020 Oct 14.
10
Causal associations between COVID-19 and atrial fibrillation: A bidirectional Mendelian randomization study.COVID-19 与心房颤动的因果关系：一项双向孟德尔随机化研究。
Nutr Metab Cardiovasc Dis. 2022 Apr;32(4):1001-1009. doi: 10.1016/j.numecd.2021.11.010. Epub 2021 Nov 20.
本文引用的文献
1
COVID-19 presenting as stroke.COVID-19 以中风为表现形式。
Brain Behav Immun. 2020 Jul;87:115-119. doi: 10.1016/j.bbi.2020.04.077. Epub 2020 Apr 28.
2
Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19.肾素-血管紧张素-醛固酮系统抑制剂与新冠病毒风险。
N Engl J Med. 2020 Jun 18;382(25):2441-2448. doi: 10.1056/NEJMoa2008975. Epub 2020 May 1.
3
Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis.新型冠状病毒病 2019（COVID-19）的患病率和严重程度：系统评价和荟萃分析。
J Clin Virol. 2020 Jun;127:104371. doi: 10.1016/j.jcv.2020.104371. Epub 2020 Apr 14.
4
Electrolyte imbalances in patients with severe coronavirus disease 2019 (COVID-19).严重新型冠状病毒病（COVID-19）患者的电解质失衡。
Ann Clin Biochem. 2020 May;57(3):262-265. doi: 10.1177/0004563220922255. Epub 2020 May 3.
5
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.意大利伦巴第地区 1591 名 ICU 收治的 SARS-CoV-2 感染患者的基线特征和结局。
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.
6
Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission.综述文章：COVID-19 的胃肠道特征和粪便传播的可能性。
Aliment Pharmacol Ther. 2020 May;51(9):843-851. doi: 10.1111/apt.15731. Epub 2020 Mar 31.
7
Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis.合并症的患病率及其对 SARS-CoV-2 感染患者的影响：系统评价和荟萃分析。
Int J Infect Dis. 2020 May;94:91-95. doi: 10.1016/j.ijid.2020.03.017. Epub 2020 Mar 12.
8
Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China.中国心血管代谢疾病对 COVID-19 的流行和影响。
Clin Res Cardiol. 2020 May;109(5):531-538. doi: 10.1007/s00392-020-01626-9. Epub 2020 Mar 11.
9
An interactive web-based dashboard to track COVID-19 in real time.一个基于网络的交互式仪表盘，用于实时追踪新冠病毒。
Lancet Infect Dis. 2020 May;20(5):533-534. doi: 10.1016/S1473-3099(20)30120-1. Epub 2020 Feb 19.
10
Warfarin Quality Metrics for Hospitalized Older Adults.住院老年人华法林质量指标
TH Open. 2018 Jul 18;2(3):e242-e249. doi: 10.1055/s-0038-1667138. eCollection 2018 Jul.
Zotero 插件